The Library of Congress > Linked Data Service
 
  Label Dataset Type Subdivision Identifier
1. United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health Examining FDA's generic drug and biosimilar user fee programs

 BIBFRAME Works
 Work
Text
Monograph		 20807661
2. United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health Examining FDA's generic drug and biosimilar user fee programs Washington: U.S. Government Publishing Office; 2018

 BIBFRAME Instances
 Instance 20807661
3. United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security Biosimilar implementation Washington: U.S. Government Publishing Office; 2017

 BIBFRAME Instances
 Instance 20144507
4. United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Assessing the impact of a safe and equitable biosimilar policy in the United States Washington: U.S. Government Printing Office; 2008

 BIBFRAME Instances
 Instance 23373684
5. Lee, Sang Joon Methodologies in biosimilar product development Boca Raton: CRC Press/Taylor & Francis Group; 2022

 BIBFRAME Instances
 Instance 22025762
6. Lee, Sang Joon Methodologies in biosimilar product development Boca Raton: CRC Press; 2022

 BIBFRAME Instances
 Instance 22027052
7. Barker, Kerry B. Biosimilar clinical development Boca Raton: CRC Press, Taylor & Francis Group; [2017]

 BIBFRAME Instances
 Instance 19142533
8. Introduction to biologic and biosimilar product development and analysis New York, NY: Springer Science+Business Media; 2018

 BIBFRAME Instances
 Instance 20618637
9. Nagel, Karen M Introduction to Biologic and Biosimilar Product Development and Analysis Cham: Springer International Publishing, Imprint: Springer; 2018

 BIBFRAME Instances
 Instance 21818203
10. United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Assessing the impact of a safe and equitable biosimilar policy in the United States Washington: U.S. G.P.O. For sale by the Supt. of Docs., U.S. G.P.O.; 2008

 BIBFRAME Instances
 Instance 15324190
11. Chow, Shein-Chung, 1955- Analytical similarity assessment in biosimilar product development Boca Raton: CRC Press,Taylor & Francis; [2019]

 BIBFRAME Instances
 Instance 20646248
12. European Generic Medicines Association EGA handbook on biosimilar medicines Brussels: European Generic Medicines Association; [2008?]

 BIBFRAME Instances
 Instance 15882109
13. Endrenyi, Laszlo Biosimilar drug product development Boca Raton: CRC Press, Taylor & Francis Group; [2017]

 BIBFRAME Instances
 Instance 19255051
14. United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security Biosimilar implementation

 BIBFRAME Works
 Work
Text
Monograph		 20144507
15. United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Assessing the impact of a safe and equitable biosimilar policy in the United States

 BIBFRAME Works
 Work
Text
Monograph		 15324190
16. Chow, Shein-Chung, 1955- Analytical similarity assessment in biosimilar product development

 BIBFRAME Works
 Work
Text
Monograph		 20646248
17. EGA handbook on biosimilar medicines

 BIBFRAME Works
 Work
Text
Monograph		 15882109
18. Biosimilar drug product development

 BIBFRAME Works
 Work
Text
Monograph		 19255051
19. United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Assessing the impact of a safe and equitable biosimilar policy in the United States

 BIBFRAME Works
 Work
Text
Monograph		 23373684
20. Methodologies in biosimilar product development

 BIBFRAME Works
 Work
Text
Monograph		 22025762


Do you need assistance with your search?